Thomas Brian C. → Metagenomi Therapeutics, Inc. MGX

Stake: — Shares: — Class: Common stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 28/100

Passive Schedule 13G filer baseline
1 independent officer/director Code-P buyer ($23,401 in ±30d)
Elevated short days-to-cover (6.3 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

3 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 6.26

1,292,216 shares short · +1.6% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-09	Reid Laurence	director	Buy	19,883	$1.17	$23K
2026-09-09	Reid Laurence	director	Buy	117	$1.18	$138
2026-06-09	BJERKHOLT ERIC	director	Award	21,000	$1.23	$26K

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →